Quality Care
HIMSS23
Stacey Caywood, CEO of Wolters Kluwer Health, discusses how Wolters Kluwer solutions incorporate diversity and inclusivity into the text, images and clinical support sources they provide to help clinicians meet patients’ care needs.
HIMSS23
Digital therapeutics improve access to care, but face reimbursement challenges. Jessica Hauflaire, COO of the Digital Therapeutics Alliance, describes the DTA's work with CMS and policymakers to gain support for this new care model.
It is a simple and low-cost model that promotes the early detection of the condition.
Sixteen accountable care organization sites will utilize NeuroFlow's platform to support clinical teams as they screen behavioral health patients.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
It aims to improve access to diagnostic services in remote areas.
HIMSS23
Dana Trampas, senior digital health specialist at HIMSS, shares how healthcare organizations can promote and advocate for LGBTQ health equity and inclusion within their patient populations and their workforces.
HIMSS23
Lawrence Whittle, CCO at Verana Health, describes how patient data can be used to improve healthcare, including making clinical trials more efficient and helping clinicians discover which treatments yield the most value.
HIMSS23
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
HIMSS23
Kathy D. Ford, chief product and strategy officer at Project Rōnin, explains how AI can help drive value-based care for oncology by empowering clinicians to find the most effective, cost-efficient treatment for each patient.